Pryv Joins The Pistoia Alliance to Lower the Barriers of Adopting Innovation in Life Sciences Research and Development

PryvAs a new member at Pistoia Alliance, Pryv joins with the mission to address the growing needs for improving the adoption of innovative technologies for patient and real-world data. Positioning itself as the next industry standard for personal and real-world data standard, Pryv is looking forward to participating in the Pistoia Alliance Community to promote collaboration as many organisations would benefit significantly from industry-wide pre-competitive collaboration.

Still, one of the biggest challenges the industry has, is transforming the growing number of collected data sets into meaningful insights via developing and implementing machine and deep learning systems.

Pryv addresses this challenge by providing the industry with a technology solution that enables data collection and standardization, storage and distribution, while allowing different and multi-algorithms to be used to identify patterns and outcomes.

Used as a foundation of R&D products development, Pryv eHealth Middleware technology ensures fast access to data and its compliant usage cross-borders. Easy access to acquiring real-world data, designing real-world data platforms and delivering real-world evidence, while ensuring the data is managed properly: preserving data privacy and security first is the promise Pryv brings to the wider Life Science community.

Benefiting from the ready-to-be used Middleware solution of Pryv, Pharmaceutical and Life Science companies can focus now primarily on their research and deliver real benefits to patients while being sure the data management is done right under their control.

The blockchain technology Pryv developed, and implemented in its Middleware is used to validate data set genuineness through its full life-cycle and provide a data trail audit, while the unique data ontology allows for granular data distribution to each stakeholder respecting Ethical, Legal and Clinical Data Requirements.

For further information, please visit:
http://pryv.com

About Pryv
Pryv is an independent Swiss SME founded in 2012 with the mission to promote, develop and implement Health IT patient-centric solutions across the healthcare industry.Pryv developed and sell licenses of a trusted Swiss-made and validated eHealth Data Middleware to empower Pharmas, Hospitals/ Clinics, Medtech, Digital Health, Insurances to build compliant, innovative and scalable data-driven eHealth products with confidence, reduced time and IT expenses while respecting complex Data Privacy Regulations.

About The Pistoia Alliance
The Pistoia Alliance is a global, not-for-profit members' organisation made up of life science companies, technology and service providers, publishers, and academic groups working to lower barriers to innovation in life science and healthcare R&D. It was conceived in 2007 and incorporated in 2009 by representatives of AstraZeneca, GSK, Novartis and Pfizer who met at a conference in Pistoia, Italy. Its projects transform R&D through pre-competitive collaboration. It overcomes common R&D obstacles by identifying the root causes, developing standards and best practices, sharing pre-competitive data and knowledge, and implementing technology pilots. There are currently over 80 member companies; members collaborate on projects that generate significant value for the worldwide life sciences R&D community, using the Pistoia Alliance’s proven framework for open innovation.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...